Indeed, in contrast to the fact that USP22 deletion resulted in a more than 50% reduction in lung metastases 4T1 cancer nodules, FoxM1 re-introduction restored USP22-null 4T1 cancer lung metastasis to a level of about 85–90% of the WT (Fig. 4H–J). The gene discussed is USP22; the disease is cancer.